HPV, Cervical Cancer, Molecular Biology, Infectious Diseases, Viral Oncology

 

American Association for the Advancement of Science (AAAS), American Association for Cancer Research (AACR), American Society for Microbiology (ASM), International Papillomavirus Society (IPV)

 

Dr. Baldwin joined St. George’s University in July, 2008 as an Assistant Professor in the School of Medicine, Department of Microbiology. She is currently Deputy Course Director for "Medical Microbiology" and serves as the Director for the medical selective / graduate course "Current Topics in Medical Virology". Dr. Baldwin also teaches on various graduate courses, SGU's undergraduate Arts & Sciences Microbiology course and enjoys serving as a Visiting Professor at UNESP, São Paulo State University, Brazil. In addition to teaching, Dr. Baldwin is conducting research projects on HPV and cervical cancer in Grenada.

Dr. Baldwin received a BS in Genetics from the University of Georgia. She completed a MS in Biological Sciences from Florida State University in Tallahassee, Florida and earned a PhD in Biomedical Sciences from the University of South Carolina, School of Medicine in Columbia, South Carolina.

While an undergraduate, Dr. Baldwin conducted research at the Environmental Protection Agency. She worked to identify microorganisms found in fresh water and soils that could degrade pesticides and herbicides. As a Research Specialist in molecular epidemiology at the Centers for Disease Control and Prevention, she investigated HIV transmission cases that were of public health concern in the Division of HIV/AIDS. Amy earned her MS while researching histone gene expression and the cell cycle. Her PhD research brought together her two main interests, viruses and dysregulation of the cell cycle. She began to study Human Papillomavirus (HPV), specifically the modulation of HPV gene expression. Dr. Baldwin continued in the HPV field as a Research Associate at Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts for five years. There she investigated host-pathogen interactions of the HPV oncoproteins in human cells through a variety of collaborations and projects.

Research awards include: USC School of Medicine Distinguished Doctorate Alumni Award 2008; Research Excellence Award, Brigham and Women’s Hospital, Biomedical Research Institute, 2007.

A Baldwin, D Grueneberg, K Hellner, W Li, J Sawyer, E Harlow and K Münger. Kinase Requirements in Human Cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3. Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12463-8. Epub 2010 Jun 28.

Baldwin, et al. “Compositions and Methods for Inhibiting Tumor Growth”, U.S.
Serial No. 61/183,8511, President and Fellows of the Harvard College and The
Brigham and Women’s Hospital, Inc. 2009

Baldwin A, Li W, Grace M, Pearlberg J, Harlow E, Münger K, Grueneberg DA.
Kinase requirements in human cells: II. Genetic interaction screens identify kinase
requirements following HPV16 E7 expression in cancer cells. Proc Natl Acad Sci
U S A. 2008 Oct 28;105(43):16478-83. Epub 2008 Oct 23.

*Grueneberg DA, *Degot S, Pearlberg J, *Li W, Davies JE, *Baldwin A, Endege W, Doench J, Sawyer J, Hu Y, Boyce F, Xian J, Munger K, Harlow E. Kinase requirements in human cells: I. Comparing kinase requirements across various cell types. Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16472-7. Epub 2008 Oct 23. (*equally contributing authors)

Baldwin A, Hypes MK, Pirisi L, Creek KE. NFI is an essential positive transcription factor for human papillomavirus type 16 early gene expression. Open Virol J. 2007;1:33-8. Epub 2007 Nov 22.

Baldwin A, Cervical Lesion Incidence and HPV in Grenada; Brochure development and publication: "Cervical Cancer Awareness: A special message for Grenadian Women"